Why the Best Drugs Fail: The Widening Medication Adherence Gap
A new PLOS Medicine Perspective argues that the widening gap between drug efficacy in trials and real-world effectiveness is driven ...
A new PLOS Medicine Perspective argues that the widening gap between drug efficacy in trials and real-world effectiveness is driven ...
A new meta-analysis of six randomized controlled trials finds that the 36 mg maintenance dose of the oral GLP-1 agonist ...
A nationwide Finnish register study of 282,307 adults examines how sociodemographic and socioeconomic factors shape who uses anti-obesity medications.
For decades, obesity medicines were judged largely by how effectively they reduced appetite. Many could help people lose weight, but ...
A groundbreaking new analysis set to be unveiled at the European Congress on Obesity (ECO 2026) in Istanbul delves into ...
A groundbreaking discovery has emerged from Georgia State University, revealing a previously unidentified group of neurons that plays a pivotal ...
Recent research published in JAMA Network Open highlights pivotal trends affecting access to semaglutide, a groundbreaking glucagon-like peptide-1 (GLP-1) receptor ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine